Nugent DJ - Search Results

1

Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency.

Lovejoy AE, Reynolds TC, Visich JE, Butine MD, Young G, Belvedere MA, Blain RC, Pederson SM, Ishak LM, Nugent DJ. Lovejoy AE, et al. Among authors: nugent dj. Blood. 2006 Jul 1;108(1):57-62. doi: 10.1182/blood-2005-02-0788. Epub 2006 Mar 23. Blood. 2006. PMID: 16556896 Free article. Clinical Trial.

2

Low platelet alpha2beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system.

Di Paola J, Federici AB, Mannucci PM, Canciani MT, Kritzik M, Kunicki TJ, Nugent D. Di Paola J, et al. Blood. 1999 Jun 1;93(11):3578-82. Blood. 1999. PMID: 10339461 Free article.

3

Current therapy for rare factor deficiencies.

Di Paola J, Nugent D, Young G. Di Paola J, et al. Haemophilia. 2001 Jan;7 Suppl 1:16-22. doi: 10.1046/j.1365-2516.2001.00100.x. Haemophilia. 2001. PMID: 11240614 Review.

4

Controversies in the treatment of pediatric immune thrombocytopenias.

Nugent DJ. Nugent DJ. Blood Rev. 2002 Mar;16(1):15-7. doi: 10.1054/blre.2001.0174. Blood Rev. 2002. PMID: 11913987 Review.

5

Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro.

Chang M, Nakagawa PA, Williams SA, Schwartz MR, Imfeld KL, Buzby JS, Nugent DJ. Chang M, et al. Among authors: nugent dj. Blood. 2003 Aug 1;102(3):887-95. doi: 10.1182/blood-2002-05-1475. Epub 2003 Apr 3. Blood. 2003. PMID: 12676790 Free article.

6

Painless urethral bleeding: an unusual presentation of Von Willebrand disease.

Armenian S, Raffel JL, Nugent DJ, Young G. Armenian S, et al. Among authors: nugent dj. Haemophilia. 2003 May;9(3):332-5. doi: 10.1046/j.1365-2516.2003.00749.x. Haemophilia. 2003. PMID: 12694526

7

Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study.

Young G, Manco-Johnson M, Gill JC, Dimichele DM, Tarantino MD, Abshire T, Nugent DJ. Young G, et al. Among authors: nugent dj. J Thromb Haemost. 2003 May;1(5):958-62. doi: 10.1046/j.1538-7836.2003.00116.x. J Thromb Haemost. 2003. PMID: 12871361 Free article.

8

Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors.

Schneiderman J, Nugent DJ, Young G. Schneiderman J, et al. Among authors: nugent dj. Haemophilia. 2004 Jul;10(4):347-51. doi: 10.1111/j.1365-2516.2004.00912.x. Haemophilia. 2004. PMID: 15230948

9

Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits.

Young G, Yonekawa KE, Nakagawa P, Nugent DJ. Young G, et al. Among authors: nugent dj. Perfusion. 2004;19(5):283-8. doi: 10.1191/0267659104pf759oa. Perfusion. 2004. PMID: 15506032

10

Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors.

Young G, McDaniel M, Nugent DJ. Young G, et al. Among authors: nugent dj. Haemophilia. 2005 May;11(3):203-7. doi: 10.1111/j.1365-2516.2005.01096.x. Haemophilia. 2005. PMID: 15876264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters